Type 1 anti-idiotypic antibodies are neutralizing antibody in immunoglobulin format. They can be used as a control for human anti-drug antibody (ADA) in bridging ELISA. Like with any other biological assay, bridging enzyme-linked immunosorbent assay (ELISA) can be influenced by several factors, some of which can cause problems if not watched carefully. The following content will discuss the most common problems and provide you with possible solutions to solve the issue. When trouble shooting, prepare all fresh buffers, sterile filter buffers containing BSA and allow all reagents to reach room temperature prior to use.
Click for the Protocol of Anti-drug Antibody (ADA) Bridging ELISA.
Contents
Poor Standard Curve
Cause | Solution |
Curve doesn’t fit scale |
|
Pipetting error | Use calibrated pipettes and proper pipetting technique. |
Poorly mixed reagents | Thoroughly mix reagents. |
Capture antibody drug did not bind well to plate |
|
Incorrect standard solution |
|
Freezing/thawing of the standard | Use fresh standard. |
The reagents are used beyond expiration date | Use fresh reagents. |
Use of non-calibrated external recombinant protein preparation as standard | Calibrate against reference preparation standard. |
Positive Results in Negative Control
Cause | Solution |
The reagents are contaminated | Use fresh reagents and pipette carefully. |
Insufficient washing of plates |
|
Too much labeled antibody drug used leading to non-specific binding | Try using less detection antibody. |
False positives in bridging experiments can result from matrix-induced bridging of biotinylated drug by dimeric or bivalent target proteins, heterophilic antibodies or rheumatoid factor. Control experiments for heterophilic antibodies or rheumatoid factor can be carried out using a molecule that is related but different from the drug. For example, for an antibody therapeutic, a biotinylated antibody of the same isotype raised in the same species can be substituted for the biotinylated drug in the bridging assay.
Weak or No Signal
Cause | Solution |
Insufficient incubation | Follow the incubation time as indicated in the protocol. |
Target concentration falls below detection limits of assay | Decrease dilution factor or concentrate samples. |
Assay set up incorrectly or used incorrect reagents | Review protocol and repeat assay using a positive control. |
Insufficient coating | Longer coating times, different coating buffers, higher coating concentration. |
Inefficient labeling |
|
Choose of anti-idiotypic antibodies | Inhibitory and neutralizing anti-idiotypic antibodies are used. |
Not enough detection reagent | Increase concentration of the detection antibody. |
Sample prepared incorrectly | Ensure proper sample preparation and dilution. |
Incubation temperature too low |
|
Plate washings too vigorous |
|
Wells dried out |
|
Slow color development |
|
Antibody quality | Use a fresh aliquot of antibody that has been stored at -20°C or below. |
Enzyme inhibitor present |
|
Too Much Signal
Cause | Solution |
Insufficient washing |
|
Plate sealers not used or reused |
|
Incorrect dilutions prepared | Check pipetting technique and double-check calculations. |
Longer incubation times than recommended | Manufactured guide has optimized protocols. Make sure to follow recommended incubation times. |
Plate left too long before reading | Take measurements shortly after addition of substrate and stop solution. |
High Background
Cause | Solution |
Insufficient washing | Increase washing cycles. |
Contaminated wash buffer | Prepare fresh water buffer. |
Suboptimal salt concentration in washing buffer | Optimize salt concentration as high concentration can reduce non-specific and/or weak off-target interaction. |
Too much detection reagent | Ensure the reagent has been diluted properly or decrease the recommended concentration of detection reagent. |
Blocking buffer ineffective | Try different blocking reagent and/or add blocking reagent to wash buffer. |
Antibody aggregation | Drug aggregates may be more prone to non-specific interactions. Use a new batch or lot. |
Non-specific binding of labeled antibody to the plate |
|
Substrate incubation carried out in light | Substrate incubations should be carried out in the dark or as recommended by manufacturer. |
Precipitate formed in wells upon substrate addition | Increase dilution factor of sample or decrease concentration of substrate. |
Dirty plate | Clean the plate bottom. |
Pipetting errors | Calibrate pipets so that they dispense the correct volumes. |
Reagents not mixed properly | Thoroughly mix all reagents and samples before pipetting solutions into wells and equilibrated to room temperature before assay. |
Plate left too long before reading | Take measurements shortly after addition of substrate and stop solution. |
Low Sensitivity
Cause | Solution |
Inactive detection reagent | Ensure reporter enzyme/fluorescent has the expected activity. |
Plate reader settings incorrect | Ensure plate reader is set to read the correct absorbance wavelength or excitation/emission wavelengths for fluorescent detection. |
Poor capture antibody adsorption to wells | Covalently link target to microtiter plate. |
Not enough substrate | Add more substrate. |
Interfering buffers or sample ingredients | Check reagents for any interfering chemicals. For example, sodium azide in antibodies inhibit HRP enzyme and EDTA used as anticoagulant for plasma collection inhibits enzymatic reactions. |
Mixing or substituting reagents from different batches | Avoid mixing components from different batches. |
Edge and Drift Effects
Cause | Solution |
Uneven temperature |
|
Solutions not at room temperature | Ensure that all solutions are at room temperature before pipetting into the wells. |
Evaporation | Seal the plate completely with a plate sealer during incubations. |
Stacked plates | Avoid stacking plates during incubation. |
Considerable interval of time elapsed during the addition of a solution |
|
Matrix Effect
ELISA quantification of plasma and serum occasionally encounters problems which are caused by the matrix effect. The matrix effect can arise from a number of matrix components including, but not limited to: interaction between endogenous biological components such as phospholipids, carbohydrates and endogenous metabolites or an interaction between the analyte of interest and the matrix, for instance covalent binding to plasma proteins. This results in erroneous sample readings. Simply diluting the samples by 2 or 5 folds reduces the matrix effect, when diluting the samples remember to use the same diluent as used for standard curve.
Poor Replicate Data
Cause | Solution |
Insufficient washing of wells |
|
Bubble in wells | Ensure no bubbles are present prior to reading plate. |
Poor mixing of samples | Ensure all reagents are mixed gently and thoroughly. |
Inconsistent sample preparation or storage | Ensure consistent sample preparation and optimal sample storage conditions. |
Cross-well contamination | Ensure plate sealers and pipette tips are not contaminated with reagents. |
Plate sealers not used or reused |
|
Inconsistent incubation temperature |
|
Exceeding concentrations of labeled detection antibody | Follow the instructions strictly. |
Variability introduced through pipetting |
|
Inconsistent shaking speed |
|
Variability introduced through plate washing equipment |
|
Edge effects |
|
Large Coefficient of Variation (CV)
Cause | Solution |
Bubbles in wells | Ensure no bubbles are present prior to reading plate. |
Wells not washed equally/thoroughly | Check that all ports of the plate washer are unobstructed. |
Incomplete reagent mixing | Ensure all reagents are mixed thoroughly. |
Inconsistent pipetting | Use calibrated pipettes and proper technique to ensure accurate pipetting. |
Edge effects | Ensure the plate and all reagents are at room temperature. |
Inconsistent sample preparation or storage | Ensure consistent sample preparation and optimal sample storage conditions (e.g. minimize freeze/thaw cycles). |
Pipetting Technique Tips for ELISA
1. Use only pipettes within the range suggested by the manufacturer.
2. Make sure tip is firmly seated on the pipette.
3. Confirm there are no air bubbles while pipetting reagents/samples/standards/controls.
4. Change tips between each standard, sample, or reagent.
5. Use different reservoirs for each reagent.
6. Pipette sample into the side of wells to avoid splashing.
7. Always run samples/standards in replicate.
Washing Procedure for ELISA
1. Completely aspirate liquid from all wells by gently lowering an aspiration tip into the bottom of each well.
Note: Take care not to scratch the inside of the well.
2. Fill the wells with at least 400 µL of diluted wash buffer.
3. Let soak for 15 to 30 seconds.
4. Aspirate wash buffer from wells.
5. Repeat as directed in protocol (usually 3-4 times).
6. After washing is complete, invert plate and tap (forcefully, if necessary) dry on absorbent tissue. Be sure to remove any residual liquid.
7. Alternatively, an automated plate washer may be used.